Compare PLETHICO PHARMA with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA DISHMAN PHARMA PLETHICO PHARMA/
DISHMAN PHARMA
 
P/E (TTM) x -1.1 25.1 - View Chart
P/BV x 0.0 3.3 0.5% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 PLETHICO PHARMA   DISHMAN PHARMA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
DISHMAN PHARMA
Mar-16
PLETHICO PHARMA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs395374 105.5%   
Low Rs31129 24.3%   
Sales per share (Unadj.) Rs604.4197.8 305.6%  
Earnings per share (Unadj.) Rs32.521.2 153.2%  
Cash flow per share (Unadj.) Rs51.334.7 147.8%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs473.6179.9 263.2%  
Shares outstanding (eoy) m34.0880.69 42.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.41.3 27.7%   
Avg P/E ratio x6.611.9 55.3%  
P/CF ratio (eoy) x4.27.2 57.3%  
Price / Book Value ratio x0.51.4 32.2%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m7,26220,306 35.8%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m1,5965,355 29.8%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m20,59815,961 129.1%  
Other income Rs m386265 145.6%   
Total revenues Rs m20,98416,226 129.3%   
Gross profit Rs m2,8184,103 68.7%  
Depreciation Rs m6421,091 58.9%   
Interest Rs m1,593944 168.7%   
Profit before tax Rs m9692,334 41.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138624 -22.2%   
Profit after tax Rs m1,1071,711 64.7%  
Gross profit margin %13.725.7 53.2%  
Effective tax rate %-14.326.7 -53.5%   
Net profit margin %5.410.7 50.1%  
BALANCE SHEET DATA
Current assets Rs m18,87711,018 171.3%   
Current liabilities Rs m11,8969,517 125.0%   
Net working cap to sales %33.99.4 360.4%  
Current ratio x1.61.2 137.1%  
Inventory Days Days36110 32.5%  
Debtors Days Days19835 567.9%  
Net fixed assets Rs m9,86116,304 60.5%   
Share capital Rs m341161 211.1%   
"Free" reserves Rs m12,33112,907 95.5%   
Net worth Rs m16,13914,516 111.2%   
Long term debt Rs m4,7064,189 112.3%   
Total assets Rs m33,14629,805 111.2%  
Interest coverage x1.63.5 46.3%   
Debt to equity ratio x0.30.3 101.0%  
Sales to assets ratio x0.60.5 116.0%   
Return on assets %8.18.9 91.4%  
Return on equity %6.911.8 58.2%  
Return on capital %12.317.5 70.1%  
Exports to sales %21.424.8 86.2%   
Imports to sales %15.23.7 407.5%   
Exports (fob) Rs m4,4023,956 111.3%   
Imports (cif) Rs m3,136596 525.9%   
Fx inflow Rs m4,4024,952 88.9%   
Fx outflow Rs m3,184697 456.9%   
Net fx Rs m1,2194,255 28.6%   
CASH FLOW
From Operations Rs m2,4372,786 87.5%  
From Investments Rs m-6,265-1,529 409.8%  
From Financial Activity Rs m2,490-941 -264.6%  
Net Cashflow Rs m-1,337316 -422.6%  

Share Holding

Indian Promoters % 82.7 61.4 134.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 3.7 116.2%  
FIIs % 5.5 12.7 43.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 22.1 33.9%  
Shareholders   10,665 46,261 23.1%  
Pledged promoter(s) holding % 85.7 35.8 239.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  CADILA HEALTHCARE  SUVEN LIFESCIENCES  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS